The online version of this article (https://doi.org/10.1007/s00125-018-4548-8) contains a slideset of the figures for download, which is available to authorised users.
Hypoglycaemia remains the most common metabolic adverse effect of insulin and sulfonylurea therapy in diabetes. Repeated exposure to hypoglycaemia leads to a change in the symptom complex that characterises hypoglycaemia, culminating in a clinical phenomenon referred to as impaired awareness of hypoglycaemia (IAH). IAH effects approximately 20–25% of people with type 1 diabetes and increases the risk of severe hypoglycaemia. This review focuses on the mechanisms that are responsible for the much higher frequency of hypoglycaemia in people with diabetes compared with those without, and subsequently how repeated exposure to hypoglycaemia leads to the development of IAH. The mechanisms that result in IAH development are incompletely understood and likely to reflect changes in multiple aspects of the counterregulatory response to hypoglycaemia, from adaptations within glucose and non-glucose-sensing cells to changes in the integrative networks that govern glucose homeostasis. Finally, we propose that the general process that incorporates many of these changes and results in IAH following recurrent hypoglycaemia is a form of adaptive memory called ‘habituation’.
Frier BM (2014) Impaired awareness of hypoglycaemia. In: Frier BM, Heller SR, McCrimmon RJ (eds) Hypoglycaemia in clinical diabetes. Wiley, India, pp 114–144 CrossRef
McCrimmon RJ, Oz G (2012) Cerebral adaptation to recurrent hypoglycemia. In: Seaquist E (ed) Translational endocrinology and metabolism: hypoglycemia in diabetes update. The Endocrine Society, Chevy Chase, MD, pp 89–114
Iqbal A, Heller SR (2017) The role of structured education in the management of hypoglycaemia. Diabetologia https://doi.org/10.1007/s00125-017-4334-z
Choudhary P, Amiel SA (2017) Hypoglycaemia in type 1 diabetes: technological treatments, their limitations and the place of psychology. Diabetologia https://doi.org/10.1007/s00125-018-4566-6
Watts AG, Donovan CM (2010) Sweet talk in the brain: glucosensing, neural networks, and hypoglycemic counterregulation. Front Neuroendocrinol 31: 32–43
Beall C, Ashford ML, McCrimmon RJ (2012) The physiology and pathophysiology of the neural control of the counterregulatory response. Am J Phys Regul Integr Comp Phys 302:R215–R223
- Impaired hypoglycaemia awareness in type 1 diabetes: lessons from the lab
Alison D. McNeilly
Rory J. McCrimmon
- Springer Berlin Heidelberg
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II